Compile Data Set for Download or QSAR
maximum 50k data
Found 171 Enz. Inhib. hit(s) with all data for entry = 132
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182959(US9670142, A21 4-benzoxazol-2-yl-N-[(1R,3S)-3-(cyc...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182961(US9670142, A23 4-benzoxazol-2-yl-N-methyl-N-((1R,3...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182962(US9670142, A24 4-benzoxazol-2-yl-N-methyl-N-((1R,3...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182964(US9670142, A26 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182965(US9670142, A27 4-benzoxazol-2-yl-N-[(1R,3S)-3-(2,2...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182863(US9670142, A1 4-benzoxazol-2-yl-N-methyl-N-((1R,3S...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182864(US9670142, A2 4-benzoxazol-2-yl-N-[(1R,3S)-3-(cycl...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182941(US9670142, A3 4-benzoxazol-2-yl-N-methyl-N-{(1R,3S...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182942(US9670142, A4 N-methyl-N-((1R,3S)-3-propionylamino...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182943(US9670142, A5 4'-chloro-biphenyl-4-carboxylic ...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182944(US9670142, A6 4-benzothiazol-2-yl-N-methyl-N-((1R,...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182945(US9670142, A7 4-(1H-benzimidazol-2-yl)-N-methyl-N-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182946(US9670142, A8 biphenyl-4-carboxylic acid methyl-((...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182947(US9670142, A9 4-(5-chloro-benzoxazol-2-yl)-N-methy...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182948(US9670142, A10 4-imidazo[1,2-a]pyrimidin-2-yl-N-me...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182950(US9670142, A12 4'-cyano-biphenyl-4-carboxylic ...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182951(US9670142, A13 4-benzoxazol-2-yl-3-methoxy-N-methy...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182952(US9670142, A14 4-(4-chloro-phenylethynyl)-N-methyl...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182953(US9670142, A15 N-methyl-N-((1R,3S)-3-propionylamin...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182954(US9670142, A16 5-benzoxazol-2-yl-pyridine-2-carbox...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182955(US9670142, A17 5-benzoxazol-2-yl-pyridine-2-carbox...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182956(US9670142, A18 N-((1R,3S)-3-acetylamino-cyclopenty...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182957(US9670142, A19 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM182971(US9670142, A29 N-((1R,3S)-3-ethylcarbamoyl-cyclope...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM183634(US9670142, A87 4-(2,3-dihydro-benzo[1,4]dioxin-6-y...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM183639(US9670142, A88 2',4'-dimethoxy-biphenyl-4-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184405(US9670142, A90 2',4'-dimethyl-biphenyl-4-c...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184406(US9670142, A91 4-(1H-benzotriazol-5-yl)-N-methyl-N...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184407(US9670142, A92 4'-chloro-2'-fluoro-bipheny...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184408(US9670142, A93 N-methyl-4-(2-oxo-2,3-dihydro-1H-be...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184409(US9670142, A94 N-methyl-4-(2-oxo-2,3-dihydro-1H-in...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184410(US9670142, A95 4-(1H-indol-5-yl)-N-methyl-N-((1R,3...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184412(US9670142, A97 2-fluoro-4'-[methyl-((1R,3S)-3-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM183615(US9670142, A79 fluoro-4'-trifluoromethoxy-biph...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184414(US9670142, A99 2'-fluoro-4'-methoxy-biphen...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184415(US9670142, A99a 4-(3-cyano-1H-indol-5-yl)-N-methyl...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184416(US9670142, A100 N-methyl-4-(3-methyl-1H-indazol-5-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184418(US9670142, A101 4-(1H-indol-5-yl)-3,N-dimethyl-N-(...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184478(US9670142, A102 N-methyl-4-(6-methyl-1H-indazol-5-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184492(US9670142, A104 5-(7-methyl-1H-indazol-5-yl)-pyrid...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184493(US9670142, A105 5-(3-methyl-1H-indazol-5-yl)-pyrid...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184499(US9670142, A106 2-fluoro-4-(1H-indol-5-yl)-N-methy...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184537(US9670142, A107 N-methyl-4-(7-methyl-1H-indazol-5-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184538(US9670142, A108 3-fluoro-N-methyl-4-(1-methyl-1H-i...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184539(US9670142, A109 5-(1H-indol-5-yl)-pyridine-2-carbo...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184540(US9670142, A110 5-(1-methyl-1H-indol-5-yl)-pyridin...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184541(US9670142, A111 2-fluoro-N-methyl-4-(1-methyl-1H-i...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184547(US9670142, A112 3-fluoro-4-(1H-indol-5-yl)-N-methy...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184550(US9670142, A113 6-(1H-indol-5-yl)-pyridazine-3-car...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid synthase(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM184573(US9670142, A114 3,N-dimethyl-4-(1-methyl-1H-indol-...)
Affinity DataIC50: <300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 171 total ) | Next | Last >>
Jump to: